ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0960

The Esophageal Epithelium in Systemic Sclerosis: Cellular and Molecular Dysregulation Revealed by Single-Cell RNA Sequencing

Matthew Dapas1, Margarette Clevenger1, Hadijat Makinde2, Tyler Therron1, Dustin Carlson1, Mary Carns3, Kathleen Aren3, Carrie Richardson2, Cenfu Wei2, Lutfiyya Muhammad4, John Pandolfino1, Harris Perlman2, Deborah Winter5 and Marie-Pier Tetreault1, 1Northwestern University, Chicago, 2Northwestern University, Chicago, IL, 3Northwestern University Division of Rheumatology, Chicago, IL, 4Northwestern Feinberg School of Medicine, Chicago, IL, 5Northwestern University, Skokie, IL

Meeting: ACR Convergence 2024

Keywords: autoimmune diseases, Bioinformatics, genomics, Scleroderma, Systemic sclerosis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 17, 2024

Title: Systemic Sclerosis & Related Disorders – Basic Science Poster I

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: Systemic sclerosis (SSc) is a rare autoimmune disease characterized by vasculopathy and progressive fibrosis of the skin and internal organs. Individuals with SSc often suffer from chronic acid reflux and dysphagia due to loss of esophageal motility. However, the pathogenesis of esophageal dysmotility in SSc is poorly understood. Recently, studies have demonstrated that esophageal epithelial cells may play a more central role in the pathogenesis of SSc esophageal dysmotility than previously thought. In this study, we performed a thorough transcriptomic investigation of the SSc esophageal epithelium in humans to determine whether distinct molecular and cellular changes in esophageal epithelial cells contribute to impaired motility of the esophagus in SSc.

Methods: We performed single-cell RNA sequencing of paired proximal and distal esophageal mucosa biopsies from 10 individuals with SSc, 4 comparator individuals with gastroesophageal reflux disease (GERD), and 6 healthy controls (HCs), which yielded 230,720 esophageal epithelial cells across 39 samples following quality control. Esophageal motility was assessed using functional luminal imaging probe panometry combined with 4-dimensional high-resolution manometry.

Results: The proportion of epithelial cells in the outermost, superficial compartment of the esophageal epithelium was significantly reduced in SSc (9.4% vs 21.6% in HCs). Differential gene expression in SSc was primarily limited to the superficial compartment (3,572 genes vs. 232 in all other compartments), with significant upregulation of extracellular matrix and keratinization genes. These cellular and molecular changes in SSc were highly correlated with those seen in GERD, indicating they were secondary to reflux; however, their magnitudes were more pronounced in the proximal esophagus, suggesting that esophageal dysmotility leads to greater proximal acid exposure, which may contribute to aspiration. Genes that were most disproportionately dysregulated in SSc compared to GERD belonged to immune-related pathways, including innate and adaptive response, antigen presentation, and metal homeostasis, and may therefore point to pathogenic mechanisms.

Conclusion: By offering a comprehensive view of transcriptional dysregulation at single-cell resolution in human esophageal epithelial cells in SSc compared to GERD and healthy tissue, this work clarifies the state of epithelial cells in SSc-induced esophageal dysfunction.


Disclosures: M. Dapas: None; M. Clevenger: None; H. Makinde: None; T. Therron: None; D. Carlson: Medpace, 2, Medtronic, 10; M. Carns: None; K. Aren: None; C. Richardson: Cabaletta Bio, 2; C. Wei: None; L. Muhammad: None; J. Pandolfino: AstraZeneca, 6, Ironwood, 2, Medtronic, 2, 6, 10, Sandhill Scientific/Diversatek, 2, 5, 6, Takeda, 6, Torax, 2, 6; H. Perlman: Abbvie, 2, AnaptysBio, 12, Speaking, advising, consulting, or providing educational programs, Exagen, 2, Janssen, 2, Kiniksa, 2; D. Winter: None; M. Tetreault: None.

To cite this abstract in AMA style:

Dapas M, Clevenger M, Makinde H, Therron T, Carlson D, Carns M, Aren K, Richardson C, Wei C, Muhammad L, Pandolfino J, Perlman H, Winter D, Tetreault M. The Esophageal Epithelium in Systemic Sclerosis: Cellular and Molecular Dysregulation Revealed by Single-Cell RNA Sequencing [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/the-esophageal-epithelium-in-systemic-sclerosis-cellular-and-molecular-dysregulation-revealed-by-single-cell-rna-sequencing/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-esophageal-epithelium-in-systemic-sclerosis-cellular-and-molecular-dysregulation-revealed-by-single-cell-rna-sequencing/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology